Your prescriber can attest that you met the clinical criteria when you first started the medication, even if your weight (and BMI) has since changed for the better
The SURMOUNT clinical trials studied participants for 72 to 88 weeks, and real-world use is expected to continue indefinitely for many patients
(It is important to note that Ozempic contains the same semaglutide ingredient as Wegovy, but at a lower dosage.) With these newly surfaced findings, the ongoing discussion surrounding the relationship between GLP-1 agonists and gastroparesis continues to captivate the medical community
Semaglutide will not appear on a standard blood panel because routine labs measure biomarkers such as blood counts, electrolytes, glucose, and lipids, not specific drug molecules
Keep your medical records and a medical necessity signed by your provider to ensure the expense is approved